* Merit Medical Systems Inc MMSI.OQ MMSI.O is expected
to show
a rise in quarterly revenue when it reports results on February
28 for the period ending December 31 2023
* The South Jordan Utah-based company is expected to report
a
9.1% increase in revenue to $320.013 million from $293.42
million a year ago, according to the mean estimate from 8
analysts, based on LSEG data.The company's guidance on October
26 2023, for the period ended December 31, was for revenue
between 309.55 million and 317.77 million.
* LSEG's mean analyst estimate for Merit Medical Systems
Inc is
for earnings of 77 cents per share. The company's EPS guidance
on October 26 2023, for the period ended December 31, was
between 0.73 and 0.78
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Merit
Medical
Systems Inc is $89.00, above its last closing price of $79.81.
The company's guidance on October 26 2023 for the period ended
December 31 was for Earnings before Interest and Taxes between
56.02855 million and 58.15191 million.The company's guidance on
October 26 2023 for the period ended December 31 was for gross
profit margin between 50.5% and 51.3%.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.65 0.65 0.75 Beat 15.9
Jun. 30 2023 0.75 0.75 0.81 Beat 7.9
Mar. 31 2023 0.55 0.55 0.64 Beat 17.2
Dec. 31 2022 0.67 0.67 0.79 Beat 17.7
Sep. 0.53 0.53 0.64 Beat 21.1
30 2022
Jun. 30 2022 0.58 0.58 0.73 Beat 26.3
Mar. 31 2022 0.47 0.47 0.53 Beat 13.9
Dec. 31 2021 0.51 0.52 0.71 Beat 36.5
This summary was machine generated February 26 at 22:43 GMT.
All figures in US dollars unless otherwise stated. (For
questions concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)